top of page

EnBiotix purchases AMP Therapeutics' anti-microbial peptide portfolio

EnBiotix has completed an asset acquisition of AMP Therapeutics (AMPT), an anti-microbial peptide portfolio firm of Boehringer Ingelheim Venture Fund and Novartis Venture Fund.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page